Which agents are commonly used for rate control in atrial fibrillation?

Which agents are commonly used for rate control in atrial fibrillation?

• A. Beta-blockers and non-dihydropyridine calcium channel blockers
• B. Digoxin only
• C. ACE inhibitors
• D. Diuretics

Answer: (A)

Rate control in atrial fibrillation is achieved by slowing the conduction through the AV node, which lowers how fast the ventricles respond to the irregular atrial activity. The most effective and commonly used agents for this are beta-blockers and non-dihydropyridine calcium channel blockers like diltiazem or verapamil. They blunt sympathetic stimulation and directly slow AV nodal conduction, which reduces the ventricular rate, improves diastolic filling, and helps relieve symptoms. They’re fast-acting, titratable, and work well in most patients who don’t have contraindications such as hypotension or decompensated heart failure. Digoxin can be useful, especially in patients with heart failure or those who are sedentary, since it increases vagal tone to slow AV nodal conduction. However, it is generally less effective during exercise or adrenergic surges and is typically not the first-line sole agent for rate control. ACE inhibitors and diuretics don’t directly slow AV nodal conduction, so they don’t serve as rate-control medications, though they address other aspects of cardiovascular management and comorbid conditions.

Rate control in atrial fibrillation is achieved by slowing the conduction through the AV node, which lowers how fast the ventricles respond to the irregular atrial activity. The most effective and commonly used agents for this are beta-blockers and non-dihydropyridine calcium channel blockers like diltiazem or verapamil. They blunt sympathetic stimulation and directly slow AV nodal conduction, which reduces the ventricular rate, improves diastolic filling, and helps relieve symptoms. They’re fast-acting, titratable, and work well in most patients who don’t have contraindications such as hypotension or decompensated heart failure.

Digoxin can be useful, especially in patients with heart failure or those who are sedentary, since it increases vagal tone to slow AV nodal conduction. However, it is generally less effective during exercise or adrenergic surges and is typically not the first-line sole agent for rate control.

ACE inhibitors and diuretics don’t directly slow AV nodal conduction, so they don’t serve as rate-control medications, though they address other aspects of cardiovascular management and comorbid conditions.